ISTH 2020 Congress Archives - ISTH Congress Abstracts

Abstract Number: PB1248

U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPS Matter Study) Interim Analysis of the 2010-2019 Birth Cohort

S. Carpenter¹, C. He², L. Malec³, A. Payne⁴, M. van den Berg³, C. Watson², C. Thornburg⁵
Abstract Number: PB0947

UK EHL Registry: Patient Reported Outcomes Measured by Haemoprefer Patient Treatment Preference and Perception Tool

P. Chowdary¹, S. Shapiro², Z. Hanif¹, N. Chadwick³, C. Tait⁴, M. Mathias⁵, S. Mangles⁶, G. Evans⁷, B. Myers⁸, D. Beech⁹, M. Makris¹⁰, K. Talks¹¹, S. Austin¹², P. Collins¹³, E. Chalmers¹⁴, E. Phillips¹⁵, J. Motwani¹⁶, G. Dolan¹⁷, C. Hay¹⁸, D. Hart¹⁹
Abstract Number: PB0518

UK NEQAS for Blood Coagulation D-Dimer Point of Care Testing Programme: A Review of Data

D.P. Kitchen, L. Brown, S. Munroe-Peart, A. Lowe, I. Jennings, S. Kitchen, I. Walker
Abstract Number: OC 08.1

Ultra High-throughput Screening Assay to Identify New Antiplatelet Drugs with Discriminative Mode of Receptor-dependent Action

D.I. Fernández¹, B.M.E. Tullemans¹, I. Provenzalle¹, J. van Groningen², J.W.M. Heemskerk¹, H. van den Hurk², M.J.E. Kuijpers¹
Abstract Number: PB1100

Ultrasound Mediated Gene Delivery Targets Liver Sinusoidal Endothelial Cells to Achieve Endothelial-specific Factor VIII Expression

M. Manson¹, C. Campbell¹, C.-Y. Chen¹, X. Cai¹, A. Vander Kooi¹, C. Miao^1,2
Abstract Number: PB0043

Un Untargeted Lipidomic Analysis Reveals Lactosylceramide as Mediator of Monocyte Migration in Coronary Artery Disease Patients

S. Fiorelli¹, S. Eligini¹, A. Anesi², C.M. Manega¹, G. Marenzi¹, N. Cosentino¹, J.P. Werba¹, B. Porro¹, V. Cavalca¹, E. Tremoli¹
Abstract Number: PB1183

Uncharacterised bleeding Disorders Are Associated with Reduced Platelet and Microparticle Thrombin Generation and Decreased Procoagulant Oxidised Phosphatidylcholine

S.G. Obaji¹, D.A. Slatter², V.J. Tyrrell², P.V. Jenkins¹, V.B. O'Donnell², P.W. Collins¹
Abstract Number: PB1209

Unclassified Bleeding Disorder (UBD)-Bleeding Phenotype and Management

O. Turan¹, A. Epstein¹, S. Halimeh², M. Siebert², R. Abdul-Kadir¹
Abstract Number: PB1588

Uncommon Types of von Willebrand Disease

P. Birke, D. Pospíšilová
Abstract Number: PB2150

Uncovering Clinical Gaps in Treatment of Cancer-Associated Thrombosis: A Clinical Practice Assessment

J. Spyropoulos, C. Padbury
Abstract Number: PB1426

Underlying Causes Greatly Influence the Development of HIT Antibodies and Clinical Outcomes in Patients with Heparin-induced Thrombocytopenia

S. Miyata^1,2, K. Kokame²
Abstract Number: PB0820

Unexpected Phenotypic Characteristics Associated with Severe Haemophilia B in Two Paediatric Patients with Deletions Involving the Whole F9 and Contiguous Genes

P. Radic¹, M. Abelleyro¹, B. Ziegler¹, V.D. Marchione¹, K. Waisman¹, L. Rossetti¹, J. Nevado², P. Lapunzina², M. Hepner³, G. Sciuccati³, C.D. De Brasi^1,4, M. Bonduel³
Abstract Number: PB0681

Unique Ready to Use, Highly Stable Multiplatform Chromogenic Assays to Facilitate Laboratory Practice

M. Peyrafitte, C. Dunois, S. Molton, J. Amiral
Abstract Number: OC 01.3

Unraveling the Protective Effects of Factor Xa Inhibition by Rivaroxaban on Atherosclerosis by RNA Sequencing

J.J. Posma¹, R. Van Oerle¹, A.C. Cleuren², M.A. Van der Ent², A. Isaacs³, M. Stoll^4,5, H. Ten Cate^1,6, H.M. Spronk¹
Abstract Number: PB0680

Updated CLOTSref: A Mobile Application for Standardized Reference Ranges in Developmental Hemostasis

P.T. Tieu^1,2, J. Chung^1,2, T.Q.H. Nguyen³, D. Matino^1,4, K. Moffat⁵, A. Chan^1,4
Abstract Number: PB2435

Upper Extremities Deep Vein Thrombosis and DOAC Treatment: a Prospective Cohort Study

M.C. Vedovati¹, G. Tratar², A. Mavri², L. Pierpaoli³, G. Agnelli¹, C. Becattini¹
Abstract Number: PB2249

Upregulation of Factor XI in End Stage Renal Disease Is Associated with Increased Thrombin Generation and D-dimer

D. Hoppensteadt¹, P. Maia¹, E. Bontekoe¹, F. Siddiqui¹, V. Bansal², J. Fareed¹
Abstract Number: PB0442

Upregulation of Inflammatory Biomarkers in Pulmonary Embolism as Studied by a Biochip- Array Profiling Approach

E. Bontekoe, E. Brailovsky, D. Hoppensteadt, F. Siddiqui, A. Farooqui, O. Iqbal, M. Latz, J. Fareed, A. Darki
Abstract Number: PB0832

Uptake of MyABDR in Australia

S. Parikh¹, J. Curtin^1,2, T. Carter^1,3, S. Brown^1,4, R. Prasad^1,5, S. Mcrae^1,6, H. Tran^1,7
Abstract Number: PB1474

Uremia Induced Pre-Activation Results in Platelet Function Impairment in Chronic Kidney Disease

C. Baaten¹, M. Sternkopf¹, E. Stamellou², T. Saritas², J. Jankowski^1,3, J. Floege², H. Noels¹
Abstract Number: PB1262

Use of ‘Virtual Clinics’ Telehealth Model in Pediatric Patients with Hemophilia and Inherited Bleeding Disorders: Experience from a Tertiary Care Center

M. Saleh¹, A. Aljefri², A. Alkofide², F. Allehaidan³, B. Abdo³, A. Amao², B. Safi⁴, V. Mohammed²
Abstract Number: PB2117

Use of a Cancer Screening Tool as Part of a Conservative Approach to Screening for Occult Malignancy after Unprovoked DVT: The King’s College Hospital Experience

C. Cox, L. Roberts, S. Guppy, R. Patel, R. Arya, J. Czuprynska
Abstract Number: PB1501

Use of a Whole Exome “Slice” for Evaluation of Inherited Platelet Disorders

K. Todd Jr.¹, W. Zhang², B. Dawson², L. Luchtman-Jones¹, J. Palumbo¹
Abstract Number: PB2132

Use of Anti-Factor Xa Levels in Cancer Patients Taking Direct Oral Anticoagulants

A. Weatherill¹, Z. Sayar¹, C. Gates¹, M. Thomas^1,2
Abstract Number: PB1026

Use of Desmopressin in the Treatment of Bleeding in Non-severe Haemophilia A

F.R. Kloosterman¹, A. Zwagemaker¹, E.A.M. Beckers², J.G. van der Bom³, M. Coppens⁴, P. Collins⁵, K. Fischer⁶, S.C. Gouw^1,3, C.R.M. Hay⁷, M.J.H.A. Kruip⁸, F.J.M. van der Meer⁹, K. Meijer¹⁰, L. Nieuwenhuizen¹¹, S. Shapiro¹², K. Fijnvandraat¹
Abstract Number: PB2098

Use of Direct Oral Anticoagulants (DOACs) as Primary or Secondary Prophylaxis of Venous Thromboembolism in Patients with Multiple Myeloma on Immunomodulatory Drugs

C. Aguilar, A.B. Dueñas, F. Sevil, C. Domínguez
Abstract Number: PB2224

Use of Direct Oral Anticoagulants in Congenital Thrombophilias

N. Montanez, M. Escobar
Abstract Number: PB1332

Use of Eltrombopag in Children with Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

G. Lassandro, V. Palladino, A. Amoruso, V.V. Palmieri, C. Pastore, G.C. Del Vecchio, P. Giordano, Italian Association of Pediatric Hematology and Oncology (AIEOP)
Abstract Number: PB0964

Use of Emicizumab Prophylaxis in Adult and Pediatric Hemophilia A Patients with and without Inhibitors: Single Center Experience

N. Montanez, D. Oldfield, S. Gustafson, J. Larson, N. Rodriguez, N. Menon, D. Brown, M. Escobar
Abstract Number: PB0700

Use of Liquid Low Molecular Weight Heparin Anti-Xa Assay for Detection of Apixaban

N. De Simone¹, F. Compton¹, S. Paulino², W. Tharpe³, M. Johns³, R. Sarode²
Abstract Number: PB2500

Use of Oral Contraceptives (OCs) and Thrombin Generation: Cross-sectional Analysis of the Longitudinal Study of Adult Health (ELSA-Brazil)

D.R. Rios¹, T. Batista¹, A.P. Silva¹, M.D.G. Carvalho¹, C. Maluf², A.L. Ribeiro², S. Barreto², R. de Figueiredo¹
Abstract Number: PB1265

Use of Prolong Parenteral Lipid Emulsions in NICU and Hematologic Disorders

G. Ambreen¹, K. Hussain², M. Sohail³, S. Javed³, U. Iazaz⁴, K. Aziz Ahmad⁴, H. Muhammad Waqar³, Z. Naz³, H. Abdul Moiz³, H. Abdul Saboor³
Abstract Number: PB0301

Use of Prothrombin Complex Concentrate for Reversal of Oral Anticoagulants in the Clinical Practice of a Portuguese Tertiary Hospital

D. Cibele, I. Machado, L. Gonçalves, C. Monteiro, M. Carvalho, C. Koch
Abstract Number: PB0291

Use of Recombinant von Willebrand Factor Alone during Surgeries in Type 2 von Willebrand Patients: Case Reports

S. Boukhlal¹, C. Loeuillet², V. Cogulet², H. Galinat³, B. Pan-Petesch⁴
Abstract Number: PB1194

Use of the ISTH Bleeding Assessement Tool in Diagnosis of Bleeding Disorders in West Algeria

D. Benlaldj^1,2, M.A. Mouedene²
Abstract Number: PB0864

Use of Thromboelastography and Thrombin Generation Assay in a Patient Treated with Emicizumab

L. Sattler¹, A.-C. Gerout², O. Feugeas³, A. Herb¹, L. Grunebaum¹, D. Desprez³
Abstract Number: PB0327

Use of Thromboelastography to Monitor Emicizumab in a Patient with Severe Haemophilia A without Inhibitor

G.L. Tiscia¹, F. Cappucci¹, A. De Laurenzo¹, D. Colaizzo¹, G. Favuzzi¹, P. Vaira², A. Ostuni³, M. Margaglione⁴, E. Grandone¹
Abstract Number: PB0456

Usefulness of D-dimers Levels Determination in the Prediction of Thromboembolic and Cardiovascular Events in Patients with Atrial Fibrillation during Anticoagulant Therapy

S. Bounaas
Abstract Number: PB1489

Usefulness of ISTH-BAT in Clinical Assessment of Inherited Platelet Disorders: Experience of the Spanish National Project

J.M. Bastida¹, M.L. Lozano², A. Marín-Quílez¹, L. Tomás-Menor³, T. Sevivas⁴, A. Rodríguez-Alén⁵, N. Butta⁶, N. Fernández-Mosteirin⁷, C. Aguilar⁸, N. Bermejo⁹, C. Sierra¹⁰, M. Lozano¹¹, M.F. López-Fernández¹², F. Velasco¹³, M.J. Varo¹⁴, M.N. Alonso¹⁵, P. Marco³, J.R. González Porras¹, A. Cid¹⁶, J. Rivera^2,17
Abstract Number: PB1172

Usefulness of Tissue Factor-Independent Coagulation Parameters for Monitoring FXI-Concentrate Replacement in Patients with FXI-Deficiency

D. Bertaggia Calderara, M.G. Zermatten, A. Aliotta, L. Alberio
Abstract Number: PB2092

Using Baseline Characteristics to Differentiate Atrial Fibrillation Prevalence and Incidence in Pulmonary Embolism

D. Patel, B. Slajus, D. Hoppensteadt, J. Fareed, E. Brailovsky, A. Darki
Abstract Number: PB2564

Utility of Fibrinogen Levels and Rotational Thrombo Elastometry (ROTEM) in Predicting Post Partum Hemorrhage

J. Kotwal¹, S.N. Jan², G. Mediratta³, H. Khullar³
Abstract Number: PB0355

Utility of Prophylactic Fresh Frozen Plasma Transfusion for Correction of Coagulopathy Prior to Image-Guided Drainage for Infected Collections

P. Porchezhian¹, A. Jain², U. Gosi³, R. Hans⁴, J. Ahluwalia⁵, P. Malhotra²
Abstract Number: PB1499

Utility of the ISTH Bleeding Assessment Tool (BATs) in Diagnosis of Glanzmann Thrombasthenia Patients – Experience from Pakistan

N. Saqlain
Abstract Number: PB1497

Utility of the ISTH Bleeding Assessment Tool and the Pediatric Bleeding Questionnaire in predicting platelet function defects in pediatric patients with excessive bleeding

D. Fedorova¹, A. Ignatova¹, D. Polokhov¹, E. Ponomarenko¹, E. Seregina¹, A. Poletaev¹, M. Panteleev², P. Zharkov¹
Abstract Number: PB1068

Utilizing Continuous Factor Infusion Replacement in a Hemophilia B Patient Undergoing Cardiac Surgery

S. Sewaralthahab^1,2, S. Farid¹, H. Smith¹